🕵️ Minerva Neurosciences, Inc. ($NERV)
SEC insider & ownership activity, last 12 months · CIK 1598646 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 19.3% | 13D | Oct 21, 2025 | filing ↗ | |
| Federated Hermes, Inc. | 17.2% | 13G | Jul 8, 2026 | filing ↗ | |
| Voting Shares Irrevocable Trust | 17.2% | 13G | Jul 8, 2026 | filing ↗ | |
| Thomas R. Donahue | 17.2% | 13G | Jul 8, 2026 | filing ↗ | |
| Ann C. Donahue | 17.2% | 13G | Jul 8, 2026 | filing ↗ | |
| J. Christopher Donahue | 17.2% | 13G | Jul 8, 2026 | filing ↗ | |
| VIVO Opportunity Fund Holdings, L.P. | 10.0% | 13G | Dec 31, 2025 | filing ↗ | |
| VIVO Opportunity, LLC | 10.0% | 13G | Dec 31, 2025 | filing ↗ | |
| VIVO Opportunity Cayman Fund, L.P. | 10.0% | 13G | Dec 31, 2025 | filing ↗ | |
| VIVO Opportunity Cayman, LLC | 10.0% | 13G | Dec 31, 2025 | filing ↗ | |
| Balyasny Asset Management L.P. | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| BAM GP LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Balyasny Asset Management Holdings LP | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Dames GP LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Dmitry Balyasny | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Coastlands Capital LP | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| Coastlands Capital Partners LP | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| Coastlands Capital GP LLC | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| Coastlands Capital LLC | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| Matthew D. Perry | 10.0% | 13G | Feb 20, 2026 | filing ↗ | |
| Joshua J. Dapice | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Dreyfuss, Philip D. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Hannah E. Dunn | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Gehani, Varun N. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Giauque, Nicolas | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Husen, Avner A. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| KIM, David T. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| LINN, Michael G. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| LUO Patrick (CHENG) | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Roberts, JR., Thomas G. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Edric C. Saito | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Daniel S. Short | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Spokes, Andrew J. M. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Warren, JOHN R. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Wehrly, MARK C. | 10.0% | 13G | Feb 5, 2026 | filing ↗ | |
| Janus Henderson Group PLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Logos Global Management LP | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Logos Global Management GP LLC | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| William Arsani | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Farallon Partners, L.L.C. | 9.5% | 13G | Feb 5, 2026 | filing ↗ | |
| Logos Opportunities Fund IV LP | 7.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Logos Opportunities Fund IV GP LLC | 7.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Graham G. Walmsley | 7.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Adage Capital Management, L.P. | 6.3% | 13G | Feb 12, 2026 | filing ↗ | |
| Robert Atchinson | 6.3% | 13G | Feb 12, 2026 | filing ↗ | |
| Phillip Gross | 6.3% | 13G | Feb 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Federated Hermes Kaufmann Fund II, A Portfolio of Federated Hermes Insurance Series | $70K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Fund II, A Portfolio of Federated Hermes Insurance Series | $70K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Small CAP Fund, A Portfolio of Federated Hermes Equity Funds | $159K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Small CAP Fund, A Portfolio of Federated Hermes Equity Funds | $159K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Fund, A Portfolio of Federated Hermes Equity Funds | $254K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Fund, A Portfolio of Federated Hermes Equity Funds | $254K | Mar 31, 2026 | filing ↗ |
| Federated Hermes Kaufmann Fund II, A Portfolio of Federated Hermes Insurance Series | $100K | Mar 10, 2026 | filing ↗ |
| Federated Hermes Kaufmann Small CAP Fund, A Portfolio of Federated Hermes Equity Funds | $2.1M | Mar 10, 2026 | filing ↗ |
| Federated Hermes Kaufmann Fund, A Portfolio of Federated Hermes Equity Funds | $3.4M | Mar 10, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material Modifications to Rights of Security Holders (3.03) | Jun 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Material agreement (1.01) | May 27, 2026 | filing ↗ |
| Other events (8.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Other events (8.01) | Apr 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 22, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 22, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 21, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 21, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 21, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing ↗ |